Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02559557 · ClinicalTrials.gov registry record · NA
Culturally Adapted Parenting Intervention for Spanish-Speaking Parents in Improving Outcomes of Younger Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia Survivors at Risk for Late Neurocognitive Effects
A NA study of Cancer Survivor and Childhood Acute Lymphoblastic Leukemia in Remission, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT02559557: Completed NA study of Cancer Survivor and Childhood Acute Lymphoblastic Leukemia in Remission, sponsored by City of Hope Medical Center.
NCT02559557 is a NA study of Cancer Survivor and Childhood Acute Lymphoblastic Leukemia in Remission that has completed, run by City of Hope Medical Center. The registered enrollment target is 38 participants, below the 265-participant average among 25 other Cancer Survivor trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02559557, a NA study of Cancer Survivor and Childhood Acute Lymphoblastic Leukemia in Remission, has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot clinical trial studies a culturally adapted skills training and educational intervention in guiding parents of younger acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML) survivors at risk for long-term attention and memory problems (late neurocognitive effects). ALL and AML treatments target the central nervous system and may put younger survivors at increased risk for late neurocognitive effects, which may lead to learning difficulties or behavior problems and poor health-related quality of life. Spanish-speaking parents of young ALL or AML survivors may not have access to the information, resources, or guidance to help their children through these difficulties. Adapting an existing parent-training program into Spanish may help teach Spanish-speaking parents effective ways to prevent or reduce learning and behavioral difficulties, which may improve the quality of life of parents and young ALL or AML survivors.
Primary Outcome
Feasibility will be operationally defined as \> 75% of parents completing the intervention.
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
- OTHER Educational Intervention
Study Locations (1)
California
- City of Hope Medical Center - Duarte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2015-10-22 |
| Est. Completion | 2016-04-18 |
| Phase | NA |
What the finished NCT02559557 record still lists
NCT02559557 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 265-participant average among 25 other Cancer Survivor trials with a reported enrollment target (86% lower).
The record links to 4 conditions, with Cancer Survivor appearing as the primary indexed condition, and to 3 interventions - of which Quality-of-Life Assessment is the first listed.
NCT02559557 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02559557 about?
NCT02559557 is a clinical study titled "Culturally Adapted Parenting Intervention for Spanish-Speaking Parents in Improving Outcomes of Younger Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia Survivors at Risk for Late Neurocognitive Effects". This pilot clinical trial studies a culturally adapted skills training and educational intervention in guiding parents of younger acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML) survivors at risk for long-term attention and memory problems (late neurocognitive effects). ALL and AM...
What is the current status of trial NCT02559557?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2015-10-22. Estimated completion is 2016-04-18.
What conditions does trial NCT02559557 study?
This clinical trial studies the following conditions: Cancer Survivor, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Cognitive Side Effects of Cancer Therapy.
What interventions are being tested in trial NCT02559557?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Educational Intervention (OTHER).
Who is sponsoring clinical trial NCT02559557?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02559557 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer Survivor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02559557's enrollment target sits among peer trials
38 21st of 25 higher than 5 of 25 other Cancer Survivor trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer Survivor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Leading Healthy Eating and Activity Promotion Program
RECRUITING · NA
-
Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors
RECRUITING · NA
-
An Acupuncture Study for Cancer Survivors With Joint Pain
RECRUITING · NA
-
Text -Based Depression Screening Among Cancer Survivors
RECRUITING · NA
-
Making Healthy Habits Stick
RECRUITING · NA
-
Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI